Home › NDC Lookup › RxCUI directory › RxCUI 1648997

Triamcinolone acetonide 0.25 MG/ML Topical Cream [Triderm] — RxCUI 1648997

RxNorm drug concept · Semantic branded drug
RxCUI 1648997 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 8 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1648997
Official nameTriamcinolone acetonide 0.25 MG/ML Topical Cream [Triderm]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asTriderm 0.025 % Topical Cream; Triderm 0.25 MG/ML Topical Cream
FDA products mapped3
Package NDCs mapped8
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Triamcinolone: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It depends on the product. Injections treat severe allergic conditions, joint inflammation, certain skin problems and eye inflammation. Creams and ointments calm itchy, inflamed sk...
  • Injections are given by a healthcare professional. Ointment is applied as a thin film to the affected area two to three times daily. Nasal spray bottles need priming before first u...
  • Possible effects include injection site pain, joint swelling, headache, muscle spasms, cough, sinusitis and bruising. People with diabetes may see higher blood sugar. Tell your doc...
  • Call right away for signs of an allergic reaction, fever or infection, a very painful and swollen joint, vision changes, or mood changes. Also report black stools, severe stomach p...
📖 Read our full Triamcinolone guide →

🕸️ Concept Web — How Triamcinolone acetonide 0.25 MG/ML Topical Cream... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Triamcinolone acetonide 0.25 MG/ML Topical Cream [Triderm] RxCUI 1648997

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Triamcinolone 10759
    • Triamcinolone acetonide 10761
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Triderm 220458
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Triamcinolone Topical Cream 377831
    • Triamcinolone acetonide Topical Cream 2648599
    • Triamcinolone Topical Product 1158231
    • Triamcinolone acetonide Topical Product 2661113
    • Triamcinolone Topical Cream [Triderm] 362100
    • Triamcinolone acetonide Topical Cream [Triderm] 2654407
    • Triderm Topical Product 1182722
    • Topical Cream 316982
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Triamcinolone acetonide 0.25 MG/ML Topical Cream SCD · 1085644
  • Triamcinolone acetonide 0.25 MG/ML SCDC · 1085643
  • Triamcinolone Topical Cream SCDF · 377831
  • Triamcinolone acetonide Topical Cream SCDFP · 2648599
  • Triamcinolone Topical Product SCDG · 1158231
  • Triamcinolone acetonide Topical Product SCDGP · 2661113

Brand-Name Concepts

  • Triamcinolone acetonide 0.25 MG/ML [Triderm] SBDC · 1648996
  • Triamcinolone Topical Cream [Triderm] SBDF · 362100
  • Triamcinolone acetonide Topical Cream [Triderm] SBDFP · 2654407
  • Triderm Topical Product SBDG · 1182722
  • Triderm BN · 220458

📦 FDA Products & Package NDCs

3 products · 8 package NDCs
8 package NDCs map to RxCUI 1648997 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00316-0165-15 1 TUBE in 1 CARTON (0316-0165-15) / 15 g in 1 TUBE TRIDERM Crown Laboratories 2015-03-25
00316-0165-16 1 JAR in 1 CARTON (0316-0165-16) / 454 g in 1 JAR TRIDERM Crown Laboratories 2015-03-25
00316-0165-85 1 TUBE in 1 CARTON (0316-0165-85) / 85.2 g in 1 TUBE TRIDERM Crown Laboratories 2015-03-25
00316-0170-01 1 TUBE in 1 CARTON (0316-0170-01) / 28.4 g in 1 TUBE TRIDERM Crown Laboratories 1984-03-19
00316-0170-02 3 g in 1 POUCH (0316-0170-02) TRIDERM Crown Laboratories 2007-11-20
00316-0170-03 1 TUBE in 1 CARTON (0316-0170-03) / 85.2 g in 1 TUBE TRIDERM Crown Laboratories 1984-03-19
00316-0175-15 1 TUBE in 1 CARTON (0316-0175-15) / 15 g in 1 TUBE TRIDERM Crown Laboratories 2015-03-25
00316-0175-16 1 JAR in 1 CARTON (0316-0175-16) / 454 g in 1 JAR TRIDERM Crown Laboratories 2017-09-01
Observed labelers: Crown Laboratories (8) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.